Apostolia M. Tsimberidou
Apostolia M. Tsimberidou, MD, PhD, FASCO, FAAAS, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine
/etc.clientlibs/mda/clientlibs/mda-web/clientlib-site/resources/images/favicon.ico
MD Anderson Cancer Center
Academic Appointments

Director of Seminars in Clinical Cancer Research, University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, Houston, TX, 2015 - 2018

Tenured Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2016

Associate Member, University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, Houston, TX, 2009 - Present

Assistant Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2010

Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2007

Instructor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2004

Administrative Appointments/Responsibilities

Wellness Lead, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present

ASCO Guideline Panel Member, Department of Use of cfDNA testing in solid tumors and lymphoma Guideline Panel, American Society of Clinical Oncology (ASCO), Washington, DC, 2022 - Present

Conquer Cancer Grant Selection Committee Member, American Society of Clinical Oncology, Washington, DC, 2021 - 2024

Member, Association for Molecular Pathology Guidance for Non-standard or Emerging NGS Applications, Bethesda, MD, 2020 - Present

Board of Directors, Personalized Medicine Coalition, Washington, DC, 2019 - Present

Committee Chair, Department of Membership Committee, Worldwide Innovative Network, Paris, 2019 - 2020

Member, Cancer LinQ Research Publications Committee, Washington, DC, 2018 - Present

Representative, MD Anderson's Official Representative at the Worldwide Innovative Network (WIN) Consortium, Paris, 2018 - 2020

FDA/ASCO Working Group, Member, The University of Texas MD Anderson Cancer Center, Washington, DC, 2017 - 2018

Past Chair, Clinical Research Committee, American Society of Clinical Oncology (ASCO), Washington, DC, 2017 - 2018

Member, Clinical Trials Committee, Worldwide Innovative Network (WIN), Paris, 2016 - 2020

ASCO Advocacy Summit Committee Member, American Society of Clinical Oncology (ASCO), Washington, DC, 2016 - Present

Chair, Clinical Research Committee, American Society of Clinical Oncology (ASCO), Washington, DC, 2016 - 2017

Steering Committee Member, Personalized Medicine Coalition (PMC), Boston, MA, 2016 - 2019

Working Group Member, Circulating Tumor DNA Analysis in Patients with Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review, Washington, DC, 2016 - 2017

Co-Chair, Molecular Tumor Board ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR), Alexandria, VA, 2015 - Present

Member, 2015 ASCO Educational Book Expert Panel, Alexandria, VA, 2015 - Present

Chair, Elect, Clinical Research Committee, American Society of Clinical Oncology (ASCO), Washington, DC, 2015 - 2016

Member, The University of Texas MD Anderson Cancer Center, Alexandria, VA, 2012 - 2014

Member, ASCO Cancer Educational Committee, Alexandria, VA, 2012 - 2015

Institutional Committee Activities

Co-Chair, Investigational Cancer Therapeutics Compassionate and Understanding Committee, 2014 - 2015